Skip to main content
. 2024 Aug 20;16(8):e67318. doi: 10.7759/cureus.67318

Table 1. Summary of target and organ-at-risk dosimetry in reference, scheduled, and adapted plans for Patient 1.

PTV: planning target volume; CTV: clinical target volume; Opt: optimized

Structure Objective Reference plan Scheduled plan Scheduled plan Adapted plan
Base plan (1.5 cm PTV) Mean ± standard deviation (Min-Max) Mean ± standard deviation (Min-Max)
CTV5500 V100% (%) >98% 89.1 82.9 66 ± 8.7 (54-89.2) 93.1 ± 2.8 (85.7-97.4)
CTV5500 V95% (%) >95% 91.3 100 69.1 ± 9.4 (57.2-91.2) 95.3 ± 2.1 (90-98.1)
CTV5500 Dmax (%) <110% 122.7 106.7 120.7 ± 1.2 (118.9-123.1) 116.7 ± 26.4 (11.8-147.2)
PTV5500 V100% (%) >95% 76.5 72.8 60.1 ± 6.6 (51.4-78.6) 78.5 ± 4 (70.3-84.4)
PTV5500 V95% (%) >95% 78.6 100 63.3 ± 6.7 (54.8-82.1) 80.7 ± 3.8 (73.3-86)
PTV5500 Dmax (%) <110% 122.7 101.1 121.5 ± 1.6 (119.4-126.5) 122.5 ± 8.9 (113-147.2)
PTVOpt V100% (%) >95% 95.1 89.2 72.7 ± 6.9 (61.3-91.4) 96.2 ± 1.3 (93-98.1)
PTVOpt V95% (%) >95% 97.2 100 76.2 ± 6.8 (65.4-93.9) 98.5 ± 0.7 (96.8-99.5)
CTVOpt V100% (%) >95% 100 93.8 87.6 ± 7 (73.7-100) 100 ± 0 (99.9-100)
PTV-CTV D5% (%) <115% 109.8 104.4 108.1 ± 1.1 (106.3-110.5) 108.9 ± 1.1 (107.3-111.2)
Small Bowel V42Gy (cc) <5 cc 2.27 64 3.3 ± 3.5 (0-14.6) 2.6 ± 1.1 (0.4-4.9)